Xavier Desobry

Xavier Desobry currently serves as the Chief of Staff for R&D Oncology at Servier, where he plays a pivotal role in shaping and executing strategic initiatives within the oncology research and development division. His deep expertise in operational management and strategic execution enables him to streamline complex processes, foster cross-functional collaboration, and ensure alignment with Servier’s overarching organizational goals. In this capacity, Xavier oversees the coordination of key projects spanning early-stage discovery to late-phase clinical development, leveraging his extensive experience in clinical study management and portfolio management to optimize resource allocation and accelerate innovation pipelines.

A core aspect of Xavier’s role involves acting as a trusted advisor to R&D leadership, facilitating decision-making processes, and driving operational excellence across the oncology department. His proficiency in budget management and financial planning ensures that projects are delivered within scope and budget, while his strategic insights help identify levers for achieving three-year objectives. Xavier’s background in clinical development, combined with his skills in transformation and operational execution, allows him to navigate the complexities of the pharmaceutical sector effectively, especially in a highly regulated environment.

His key projects often focus on advancing novel oncology therapies, optimizing clinical trial strategies, and implementing innovative operational frameworks that enhance efficiency and agility. Xavier’s ability to synthesize industry trends with internal capabilities positions him as a vital contributor to Servier’s mission to develop impactful cancer treatments. With over a decade of experience working closely with R&D managers and leadership teams, Xavier Desobry continues to drive impactful change, fostering a culture of operational excellence and strategic agility within the oncology research landscape.